Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes

Am J Hematol. 2018 Dec;93(12):E398-E401. doi: 10.1002/ajh.25287. Epub 2018 Oct 9.

Authors

Affiliations

¹ Division of Hematology, Mayo Clinic, Rochester, Minnesota.
² Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, Minnesota.
³ Department of Clinical Genomics, Mayo Clinic, Rochester, Minnesota.
⁴ Division of Hematopathology, Mayo Clinic, Rochester, Minnesota.

PMID: 30218541
DOI: 10.1002/ajh.25287

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Cell Size
Chromosome Aberrations*
Clone Cells / pathology*
Female
Humans
Male
Middle Aged
Myelodysplastic Syndromes / diagnosis*
Myelodysplastic Syndromes / genetics
Myelodysplastic Syndromes / mortality
Myelodysplastic Syndromes / pathology
Prognosis
Retrospective Studies
Survival Rate
Young Adult